Phosphoinositide 3-kinases: a conserved family of signal transducers.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  TIBS -Trends in Biochemical Sciences. Regular ed

• Publication date

  1997-07-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0968-0004(97)01061-XPMID 9255069
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• C. Elegans II

  1998cited by this paper
• Characterization of p150, an Adaptor Protein for the Human Phosphatidylinositol (PtdIns) 3-Kinase

  1997cited by this paper
• P110delta, a novel phosphoinositide 3-kinase in leukocytes.

  1997cited by this paper
• R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways.

  1997cited by this paper
• Genetic Quest for the Fountain of Youth

  1997cited by this paper
• Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras.

  1997cited by this paper
• Akt Signaling--Linking Membrane Events to Life and Death Decisions

  1997cited by this paper
• Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

  1997cited by this paper
• p60 Is an Adaptor for the DrosophilaPhosphoinositide 3-Kinase, Dp110*

  1997cited by this paper
• PH domains--a universal membrane adapter.

  1997cited by this paper
• UPDATE: PH Domains--A Universal Membrane Adapter

  1997cited by this paper
• The G beta gamma sensitivity of a PI3K is dependent upon a tightly associated adaptor, p101.

  1997cited by this paper
• PI3K: downstream AKTion blocks apoptosis.

  1997cited by this paper
• Phosphoinositide kinases.

  1996cited by this paper
• A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans

  1996cited by this paper
• Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB

  1996cited by this paper
• Ras effectors.

  1996cited by this paper
• Phosphoinositides as Regulators in Membrane Traffic

  1996cited by this paper
• Mechanism of activation of protein kinase B by insulin and IGF‐1.

  1996cited by this paper
• The pleckstrin homology domain: An intriguing multifunctional protein module

  1996cited by this paper
• A signaling pathway to translational control.

  1996cited by this paper
• The Drosophila phosphoinositide 3‐kinase Dp110 promotes cell growth.

  1996cited by this paper
• Genetic analysis of the roles of daf-28 and age-1 in regulating Caenorhabditis elegans dauer formation.

  1996cited by this paper
• Platelet-derived growth factor-dependent activation of phosphatidylinositol 3-kinase is regulated by receptor binding of SH2-domain-containing proteins which influence Ras activity

  1996cited by this paper
• The study of phosphoinositide 3-kinase function.

  1996cited by this paper
• Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase.

  1996cited by this paper
• GSK3: a SHAGGY frog story.

  1996cited by this paper
• The Drosophila insulin receptor is required for normal growth.

  1996cited by this paper
• Phosphoinositide 3-kinases and membrane traffic.

  1996cited by this paper
• Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor Fc(gamma)RIIB.

  1996cited by this paper
• p70 S6 kinase: an enigma with variations.

  1996cited by this paper
• Structural and functional diversity of phosphoinositide 3-kinases.

  1996cited by this paper
• Activation of phosphoinositide 3‐kinase by interaction with Ras and by point mutation.

  1996cited by this paper
• Invertebrate gerontology: The age mutations of Caenorhabditis elegans

  1996cited by this paper
• PDGF stimulates an increase in GTP-Rac via activation of phosphoinositide 3-kinase.

  1995cited by this paper
• A family of phosphoinositide 3-kinases in Drosophila identifies a new mediator of signal transduction.

  1995cited by this paper
• Phospholipid signaling.

  1995cited by this paper
• Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

  1995cited by this paper
• When is a lipid kinase not a lipid kinase? When it is a protein kinase.

  1995cited by this paper
• Activation of PRK1 by Phosphatidylinositol 4,5-Bisphosphate and Phosphatidylinositol 3,4,5-Trisphosphate

  1995cited by this paper
• Ras-dependent induction of cellular responses by constitutively active phosphatidylinositol-3 kinase.

  1995cited by this paper
• A phosphatidylinositol (PI) kinase gene family in Dictyostelium discoideum: biological roles of putative mammalian p110 and yeast Vps34p PI 3-kinase homologs during growth and development

  1995cited by this paper
• Genes that regulate both development and longevity in Caenorhabditis elegans.

  1995cited by this paper
• Protein Kinase C: Seeing two domains

  1995cited by this paper
• Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase.

  1995cited by this paper
• The 70 kDa S6 kinase: regulation of a kinase with multiple roles in mitogenic signalling.

  1995cited by this paper
• Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

  1995cited by this paper
• Structure, regulation and function of phosphoinositide 3-kinases.

  1994cited by this paper
• The activation of phosphatidylinositol 3-kinase by Ras.

  1994cited by this paper
• Phosphatidylinositol-3-OH kinase direct target of Ras

  1994cited by this paper
• Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system?

  1993cited by this paper
• An essential role for a protein and lipid kinase complex in secretory protein sorting.

  1992cited by this paper
• Phosphoinositide kinases.

  1990cited by this paper
• A method for the isolation of longevity mutants in the nematode Caenorhabditis elegans and initial results.

  1983cited by this paper
• The nematode Caenorhabditis elegans.

  1980cited by this paper

• Norisoboldine Induces Endothelium-Dependent Vasorelaxation and Attenuates Hypertension by Modulating Ca2+-eNOS Signaling, Oxidative Stress, and Inflammation

  2026cites this paper
• Identification of PI3K gene family in large yellow croaker (Larimichthys crocea): Expression patterns under Pseudomonas plecoglossicida infection and hypoxia stress, and functional verification of pik3r3b.

  2026cites this paper
• Cell cycle dependence of ERK activation dynamics is regulated by PI3K and PAK1 signaling

  2025cites this paper
• Design, synthesis and bioactive evaluation of novel quinoline-linked sulfonamide-pyridine derivatives as PI3K/HDAC dual-target inhibitors.

  2025cites this paper
• The constitutive oncogenic and signaling activities of phosphatidylinositol 3-kinase (PI3K) isoforms p110β and p110δ

  2025cites this paper
• Understanding the conformational dynamics of PI3Kα due to helical domain mutations: insights from Markov state model analysis

  2025cites this paper
• Expert insights on Hodgkin’s lymphoma development in an activated PI3K delta syndrome patient undergoing leniolisib treatment

  2025cites this paper
• Early phase development of PI3kinase inhibitors for anticancer therapies

  2025cites this paper
• A combined opposite targeting of p110δ PI3K and RhoA abrogates skin cancer

  2024cites this paper
• Discovery of Pyridopyrimidinones that Selectively Inhibit the H1047R PI3Kα Mutant Protein

  2024cites this paper
• CDK12 is a promising therapeutic target for the transcription cycle and DNA damage response in metastatic osteosarcoma.

  2024cites this paper
• The essential roles of lncRNAs/PI3K/AKT axis in gastrointestinal tumors

  2024cites this paper
• A Comprehensive Review on Phosphatidylinositol-3-Kinase (PI3K) and its Inhibitors Bearing Pyrazole or Indazole Core for Cancer Therapy.

  2024cites this paper
• Subunit-Specific Developmental Roles of PI3K in SF1-Expressing Cells

  2024cites this paper
• Comparative Analyses of Dynamic Transcriptome Profile of Heart Highlight the Key Response Genes for Heat Stress in Zhikong Scallop Chlamys farreri

  2024cites this paper
• Divergent roles of the regulatory subunits of class IA PI3K

  2024cites this paper
• Structural modeling of phosphatidylinositol 3-kinase-γ with novel derivatives of stilbenoids

  2024cites this paper
• Role of m6A modification in regulating the PI3K/AKT signaling pathway in cancer

  2023cites this paper
• New insights in photodynamic inactivation of Leishmania amazonensis: A focus on lipidomics and resistance

  2023cites this paper
• Structural and mechanistic insights provided by single particle cryo-EM analysis of phosphoinositide 3-kinase (PI3Kα).

  2023cites this paper
• Application of an "inhalation by design" approach to the identification and in-vitro evaluation of novel purine based PI3Kδ inhibitors.

  2023cites this paper
• Angiogenesis and prostate cancer: MicroRNAs comes into view.

  2023cites this paper
• Function-oriented synthesis of Imidazo[1,2-a]pyrazine and Imidazo[1,2-b]pyridazine derivatives as potent PI3K/mTOR dual inhibitors.

  2022cites this paper
• Class I PI3K Biology.

  2022cites this paper
• Regulatory role of JMJD6 in placental development

  2022cites this paper
• Neutrophil Survival Signaling During Francisella tularensis Infection

  2022cites this paper
• Targeting Metabolic Reprogramming of T-Cells for Enhanced Anti-Tumor Response

  2022cites this paper
• BTT_A_365490 35..45

  2022cites this paper
• Periostin: an emerging activator of multiple signaling pathways.

  2022cites this paper
• Republication: Targeting PI3KC2β Impairs Proliferation and Survival in Acute Leukemia, Brain Tumours and Neuroendocrine Tumours

  2022cites this paper
• Claspin is Required for Growth Recovery from Serum Starvation through Regulating the PI3K-PDK1-mTOR Pathway in Mammalian Cells

  2022cites this paper
• PIK3CA Mutations Drive Therapeutic Resistance in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer

  2022cites this paper
• Unveiling molecular insights into the mechanism of activation of oncogenic phosphoinositide 3-kinase mutants

  2022cites this paper
• Effect of a high‐fat meal on the relative bioavailability of HMPL‐689 in Chinese healthy volunteers

  2022cites this paper
• G Protein-Coupled Receptor Signaling: Transducers and Effectors.

  2022cites this paper
• Development of PI3Kα inhibitors for tumor therapy

  2022cites this paper
• Discovery of novel selective PI3Kγ inhibitors through combining machine learning-based virtual screening with multiple protein structures and bio-evaluation

  2021cites this paper
• Placental Angiogenesis in Mammals: A Review of the Regulatory Effects of Signaling Pathways and Functional Nutrients.

  2021cites this paper
• Sirtuins-Mediated System-Level Regulation of Mammalian Tissues at the Interface between Metabolism and Cell Cycle: A Systematic Review

  2021cites this paper
• Mechanisms of Resistance to PI3K Inhibitors in Cancer: Adaptive Responses, Drug Tolerance and Cellular Plasticity

  2021cites this paper
• The PI3Kδ inhibitor parsaclisib ameliorates pathology and reduces autoantibody formation in preclinical models of systemic lupus erythematosus and Sjӧgren's syndrome.

  2021cites this paper
• PI3K INHIBITION IN BREAST CANCER: IDENTIFYING AND OVERCOMING DIFFERENT FLAVORS OF RESISTANCE.

  2021cites this paper
• Orbital Signaling in Graves’ Orbitopathy

  2021cites this paper
• Potential Roles of Endoplasmic Reticulum Stress and Cellular Proteins Implicated in Diabesity

  2021influential citation
• Distinct epithelial-to-mesenchymal transitions induced by PIK3CAH1047R and PIK3CB

  2021cites this paper
• An RNAi screen of the kinome in epithelial follicle cells of the Drosophila melanogaster ovary reveals genes required for proper germline death and clearance

  2021cites this paper
• Overview of the regulation of the class IA PI3K/AKT pathway by SUMO.

  2021cites this paper
• miRNA regulation of G protein-coupled receptor mediated angiogenic pathways in cancer

  2021cites this paper
• Exploring the ‘Dormancy Activation Switch’ in the Tumour Microenvironment for Metastatic Lung Cancer: The Possible Role of MicroRNA

  2021cites this paper
• Cryo-EM structures of PI3Kα reveal conformational changes during inhibition and activation

  2021cites this paper
• p52Shc regulates the sustainability of ERK activation in a RAF-independent manner

  2021cites this paper
• The PI3K/Akt/mTOR axis in colorectal cancer: Oncogenic alterations, non‐coding RNAs, therapeutic opportunities, and the emerging role of nanoparticles

  2021cites this paper
• Combinatorial treatment with Gefitinib and Bay11-7085 sensitizes primary Gefitinib-resistant OSCC cells by influencing the EGFR- NFκB signaling axis

  2021cites this paper
• Targeting the PI3K/AKT/mTOR Signaling Pathway in Primary Central Nervous System Lymphoma: Current Status and Future Prospects.

  2020cites this paper
• PI3K/AKT/mTOR signaling in gastric cancer: Epigenetics and beyond.

  2020cites this paper
• Recent advances in small molecular modulators targeting histone deacetylase 6

  2020cites this paper
• Bidirectional differentiation of BMSCs induced by a biomimetic procallus based on a gelatin-reduced graphene oxide reinforced hydrogel for rapid bone regeneration

  2020cites this paper
• Discovery of the Potent Phosphoinositide 3‐Kinase δ (PI3 K δ) Inhibitors

  2020cites this paper
• Untersuchung spezifischer Inhibitoren der PI3K-Signalkaskade zur Therapie des Lymphangioms

  2020cites this paper
• Protease-activated receptor 4 causes Akt phosphorylation independently of PI3 kinase pathways

  2020cites this paper
• Investigating the role of Class-1 Phosphoinositide 3 Kinases (PI3Ks) in insulin signaling and obesity

  2020cites this paper
• C-Src Is Activated by the EGF Receptor in a Pathway that Mediates JNK and ERK Activation by Gonadotropin-Releasing Hormone in COS7 Cells

  2020cites this paper
• Recent Progress in the Development of Quinoline Derivatives for the Exploitation of Anti-cancer Agents.

  2020cites this paper
• p110δ PI3K as a therapeutic target of solid tumours.

  2020cites this paper
• Shenfu Injection Promotes Vasodilation by Enhancing eNOS Activity Through the PI3K/Akt Signaling Pathway In Vitro

  2020cites this paper
• Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway

  2020influential citation
• IL-7R gene variants are associated with breast cancer susceptibility in Chinese Han women.

  2020cites this paper
• Correlation between IL‐7R gene variants and breast cancer susceptibility in Chinese Han women

  2020cites this paper
• Structural and functional characterization of Solanum lycopersicum phosphatidylinositol 3-kinase C2 domain.

  2020cites this paper
• The endocrinological component and signaling pathways associated to cardiac hypertrophy.

  2020cites this paper
• PI 3 ‐ kinase isoforms at the crossroads of signalling and vesicular traffic

  2019cites this paper
• PBT-6, a Novel PI3KC2γ Inhibitor in Rheumatoid Arthritis

  2019cites this paper
• Studies of PDGF receptor signaling in vitro and in vivo

  2019cites this paper
• RAS Mutations in Human Cancers: Roles in Precision Medicine.

  2019cites this paper
• Anticancer compound XL765 as PI3K/mTOR dual inhibitor: A structural insight into the inhibitory mechanism using computational approaches

  2019cites this paper
• Adiponectin and Serine/Threonine Kinase Akt Modulation by Triiodothyronine and/or LY294002 in 3T3-L1 Adipocytes.

  2019cites this paper
• PI3K isoforms in cell signalling and vesicle trafficking

  2019cites this paper
• Overview of Targeted Drugs for Mature B-Cell Non-hodgkin Lymphomas

  2019cites this paper
• Carbohydrate Kinases: A Conserved Mechanism Across Differing Folds

  2019cites this paper
• Investigating the roles that G protein-coupled receptor kinase 2 plays in arterial smooth muscle proliferation

  2019cites this paper
• PIK3CA in cancer: The past 30 years.

  2019cites this paper
• The Two Sides of the Same Coin-Influenza Virus and Intracellular Signal Transduction.

  2019cites this paper
• Molecularly Distinct Clathrin-Coated Pits Differentially Impact EGFR Fate and Signaling

  2019cites this paper
• Drosophila melanogaster as a Model for Diabetes Type 2 Progression

  2018cites this paper
• Effect of endurance and high intensity interval swimming training on cardiac hypertrophy of male rats

  2018cites this paper
• Cantharidin suppresses cell growth and migration, and activates autophagy in human non-small cell lung cancer cells.

  2018cites this paper
• Aggravation of inflammation-induced encephalopathy by reduced ambient temperature – Role of phosphoinositide 3-kinase gamma

  2018cites this paper
• The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts.

  2018cites this paper
• 19 Caveolar Vesicles in Cellular Senescence

  2018cites this paper
• Qualitative and semi-quantitative analysis of signal transduction networks

  2018cites this paper
• Curcumin‐induced autophagy and nucleophagy in Spodoptera frugiperda Sf9 insect cells occur via PI3K/AKT/TOR pathways

  2018cites this paper
• A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer

  2018cites this paper
• Monitoring and Management of Toxicities of Novel B Cell Signaling Agents

  2018cites this paper
• Synthesis, biological evaluation and structure-activity relationship of a novel class of PI3Kα H1047R mutant inhibitors.

  2018cites this paper
• Virtual screening of naphthoquinone analogs for potent inhibitors against the cancer‐signaling PI3K/AKT/mTOR pathway

  2018cites this paper
• Hepatic miR‐125b inhibits insulin signaling pathway by targeting PIK3CD

  2018cites this paper
• Cell-type specific role of phosphoinositide 3- kinase in inflammatory-induced cholestasis

  2018cites this paper
• Influence of the two negative regulators SHIP1 and Lyn on the antigen-induced mast cell phenotype

  2018cites this paper
• Pharmacological inactivation of the PI3K p110δ prevents breast tumour progression by targeting cancer cells and macrophages

  2018cites this paper
• High-throughput screening campaigns against a PI3Kα isoform bearing the H1047R mutation identified potential inhibitors with novel scaffolds

  2018cites this paper